News
1d
MedPage Today on MSNFDA Approves Label Change for Alzheimer's Amyloid DrugDonanemab was approved by the FDA in July 2024 to treat adults with early symptomatic Alzheimer's disease with confirmed ...
19h
Stocktwits on MSNEli Lilly’s Alzheimer’s Drug Gets US FDA Label Update For More Gradual Dosing After Study Shows Reduced Side EffectsEli Lilly and Company (LLY) announced on Wednesday that the U.S. Food and Drug Administration (FDA) has approved a label ...
The FDA will allow a new dosing schedule for Eli Lilly’s Alzheimer’s drug Kisunla that could lessen a known side effect of ...
The U.S. Food and Drug Administration is revising the labeling of all extended-release attention-deficit/hyperactivity ...
The U.S. Food and Drug Administration said on Monday it is revising the labeling of all extended-release stimulants used to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results